Selective disruption of the cerebral neocortex in Alzheimer's disease
about
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseasePreclinical Alzheimer disease: identification of cases at risk among cognitively intact older individualsImaging structural co-variance between human brain regionsFreeSurferAltered brain response for semantic knowledge in Alzheimer's diseaseCSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's diseasePerturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease.The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis.The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.Early indications of future cognitive decline: stable versus declining controlsStructural brain changes in normal individuals with a maternal history of Alzheimer's.Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.Emerging β-amyloid pathology and accelerated cortical atrophy.The dynamics of cortical and hippocampal atrophy in Alzheimer disease.Episodic memory on the path to Alzheimer's disease.Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.Spatial navigation-a unique window into physiological and pathological agingWithin-subject template estimation for unbiased longitudinal image analysis.Soluble α-synuclein is a novel modulator of Alzheimer's disease pathophysiology.The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects.Memory after silent stroke: hippocampus and infarcts both matter.Neuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-β in Mild Cognitive Impairment.Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways.An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer diseaseWhite matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration.Structural covariance of the default network in healthy and pathological aging.Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal agingRegional and Gender Study of Neuronal Density in Brain during Aging and in Alzheimer's Disease.Interleukin-8 and interleukin-10, brain volume and microstructure, and the influence of calorie restriction in old rhesus macaques.Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease.Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.Understanding the cause of sporadic Alzheimer's disease.Case Studies Illustrating Focal Alzheimer's, Fluent Aphasia, Late-Onset Memory Loss, and Rapid Dementia.Default network correlations analyzed on native surfaces.Association of silent lacunar infarct with brain atrophy and cognitive impairment.Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits.Multivariate regression analysis of structural MRI connectivity matrices in Alzheimer's disease.Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.
P2860
Q24595802-80CC3C5E-9806-4BEF-B9EB-8B99F0B9E195Q26995405-634B3520-80E4-42AE-870D-73698BFDF0E8Q27022385-68D58E44-F0A6-4537-A962-B70FC7892770Q28124699-93770C4A-3F97-492E-8D65-CB880CD4379DQ28386974-4681B60F-219B-4479-82C1-38F94E62FC2BQ28728773-72FE6E83-6AD4-4D47-977E-96EB2FF62EF8Q30586952-DA7ED887-F90C-482A-A000-6C78DE3292AFQ33565271-78520435-77FE-4F7C-A332-743C25D12F44Q34296479-74EF2529-2AF2-4C62-BD0F-6FC53A52021BQ34989712-3F5DE89C-A574-454F-A875-0C9210B148ABQ35046339-4F317BC2-03E7-42FB-99BD-D758D04FC907Q35219292-5BFD8313-5E77-416C-91EB-8E86F2206296Q35542164-5B7FF178-95CE-41B7-B337-A1DC4A6FA94CQ35643088-41D17418-6412-4FB3-A551-86322C744DE1Q35663255-75150F73-7E77-4892-90A5-AEE0073DFA34Q35787932-9B78FEF8-4DF7-4865-96F0-7157D0E93B97Q36049538-204F0E94-FEA7-44C0-A398-B762E872CD40Q36075413-473381DB-7BA9-409F-B602-DDE130CD0DE5Q36182604-BFA6828A-2272-4708-A686-C9EBD19B6B59Q36297979-74C8EEC4-1731-4479-8D8D-A120F858BE81Q36304071-DC0BA7B8-36B1-4546-BDE0-F2D233967176Q36426322-A6DAFCE9-92C7-4C68-A490-07527393F460Q36540471-22C35FBD-F9B5-4F58-9A1B-8A8767221D55Q36650399-CAB71130-1802-4E65-84E0-E62DB8015AC2Q37106748-6FF4E7AD-8181-4078-A664-D6843A456381Q37179776-2B77AB32-413B-4291-9835-E6A0748FFA4FQ37220884-A48C0234-E592-495D-AFDE-6C8D47FA0EDCQ37250497-49411476-F42C-461A-85A4-211DF31D6EC0Q37300600-7034F68A-AD23-453A-98D2-ED1ABD06A6C2Q37524486-439912FB-06B5-48BD-8F95-782FB0336DA2Q37896029-6D533C66-24E8-46A9-832B-E172BE9FE415Q38170374-14B9CE39-205F-429A-B5B7-6A3E9C7F3D0AQ38213834-9B9CEFE4-C6F1-4549-B2B5-14D4CE69F0ABQ38389822-92E17815-DA87-4A33-8BF4-F5D4E1C18C92Q41953882-1E6D5EC1-FD12-402D-A798-631857C750EEQ46101591-1B776A40-909F-40DD-B327-9773DF534F7CQ46362244-4A143F65-B3B5-4A5C-A8FA-9E92681066E4Q46656646-F0016DD5-B3BB-4BC3-B5C4-EC422A125D79Q47574138-117E7B56-219A-472A-B089-0FCC797B0552Q47891276-B5CD4215-2CD0-426F-B92C-A93F13EF3844
P2860
Selective disruption of the cerebral neocortex in Alzheimer's disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Selective disruption of the cerebral neocortex in Alzheimer's disease
@ast
Selective disruption of the cerebral neocortex in Alzheimer's disease
@en
type
label
Selective disruption of the cerebral neocortex in Alzheimer's disease
@ast
Selective disruption of the cerebral neocortex in Alzheimer's disease
@en
prefLabel
Selective disruption of the cerebral neocortex in Alzheimer's disease
@ast
Selective disruption of the cerebral neocortex in Alzheimer's disease
@en
P2093
P2860
P50
P1433
P1476
Selective disruption of the cerebral neocortex in Alzheimer's disease
@en
P2093
Alessandro Biffi
David H Salat
Nicholas J Schmansky
Rahul S Desikan
Reisa A Sperling
P2860
P304
P356
10.1371/JOURNAL.PONE.0012853
P407
P50
P577
2010-09-23T00:00:00Z